W Conrad Liles Selected Research

Interleukin-6 (Interleukin 6)

1/2023	Plasma Interleukin-6 (IL-6), Angiopoietin-2, and C-Reactive Protein Levels Predict Subsequent Type 1 Myocardial Infarction in Persons With Treated HIV Infection.
12/2022	Plasma Interleukin-6 Predicts Clinical Decline After Completion of Dexamethasone Therapy in Severe COVID-19.
11/2021	Elevated Plasma von Willebrand Factor Levels Are Associated With Subsequent Ischemic Stroke in Persons With Treated HIV Infection.
1/2021	Comparison of host endothelial, epithelial and inflammatory response in ICU patients with and without COVID-19: a prospective observational cohort study.
1/2020	Interleukin-6 improves infection identification when added to physician judgment during evaluation of potentially septic patients.
1/2019	Boiling Histotripsy Ablation of Renal Cell Carcinoma in the Eker Rat Promotes a Systemic Inflammatory Response.
4/2017	Lung pericyte-like cells are functional interstitial immune sentinel cells.
1/2017	Circulating levels of soluble Fas (sCD95) are associated with risk for development of a nonresolving acute kidney injury subphenotype.
5/2012	Host immune response in returning travellers infected with malaria.
6/2011	Hematopoietic Fas deficiency does not affect experimental atherosclerotic lesion formation despite inducing a proatherogenic state.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

W Conrad Liles Research Topics

Disease

46	Infections 01/2024 - 05/2002
36	Inflammation (Inflammations) 01/2024 - 06/2003
34	Malaria 12/2020 - 05/2008
28	Sepsis (Septicemia) 01/2024 - 01/2006
17	Critical Illness (Critically Ill) 12/2023 - 08/2006
12	Acute Lung Injury 01/2024 - 09/2005
12	Cerebral Malaria 01/2017 - 11/2006
9	Lung Injury 01/2024 - 09/2005
8	COVID-19 12/2023 - 01/2021
7	Pneumonia (Pneumonitis) 01/2022 - 03/2004
6	Acute Kidney Injury (Acute Renal Failure) 07/2023 - 10/2016
5	Respiratory Insufficiency (Respiratory Failure) 07/2023 - 08/2006
5	Thrombosis (Thrombus) 01/2023 - 02/2016
5	Fever (Fevers) 12/2022 - 09/2009
5	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020 - 06/2004
5	Septic Shock (Toxic Shock Syndrome) 01/2019 - 04/2011
5	Communicable Diseases (Infectious Diseases) 08/2013 - 05/2002
4	Cystic Fibrosis (Mucoviscidosis) 01/2024 - 01/2020
4	Wounds and Injuries (Trauma) 07/2023 - 01/2019
4	HIV Infections (HIV Infection) 01/2023 - 08/2013
4	Human Influenza (Influenza) 01/2021 - 07/2011
4	Falciparum Malaria (Plasmodium falciparum Malaria) 03/2013 - 09/2009
3	Fibrosis (Cirrhosis) 01/2024 - 01/2018
3	Necrosis 01/2022 - 01/2009
3	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2020 - 01/2017
3	Neoplasms (Cancer) 01/2019 - 11/2017
2	Bacterial Infections (Bacterial Infection) 01/2024 - 01/2023
2	Weight Loss (Weight Reduction) 01/2024 - 01/2023
2	Shock 12/2022 - 04/2011
2	Thrombocytopenia (Thrombopenia) 11/2017 - 02/2012
2	Cytokine Release Syndrome 11/2017 - 07/2011
2	Anemia 11/2016 - 10/2016
2	Reperfusion Injury 03/2016 - 01/2013
2	Multiple Organ Failure (MODS) 02/2016 - 01/2006
2	Ventilator-Associated Pneumonia 01/2016 - 08/2006
2	Bacteremia 01/2016 - 01/2013

Drug/Important Bio-Agent (IBA)

45	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2009
19	CytokinesIBA 01/2023 - 05/2002
16	Angiopoietin-2IBA 01/2023 - 02/2011
15	Angiopoietin-1IBA 11/2021 - 09/2007
12	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2006
9	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 01/2011
8	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2017 - 07/2005
7	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 11/2021 - 01/2011
7	ArtesunateIBA 11/2016 - 01/2011
6	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2013
5	LipopolysaccharidesIBA 01/2022 - 03/2004
5	InterferonsIBA 04/2020 - 05/2002
5	Antimalarials (Antimalarial Agents)IBA 01/2016 - 09/2009
5	AngiopoietinsIBA 01/2016 - 01/2009
4	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 07/2023 - 01/2017
4	InterleukinsIBA 12/2022 - 01/2014
4	von Willebrand FactorIBA 01/2022 - 08/2013
4	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2021 - 07/2013
4	Lactic Acid (Lactate)FDA LinkGeneric 01/2020 - 04/2014
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019 - 07/2011
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 01/2003
3	Therapeutic UsesIBA 01/2022 - 05/2002
3	ChemokinesIBA 01/2020 - 05/2012
3	Chimeric Antigen ReceptorsIBA 01/2020 - 11/2017
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2017 - 09/2009
3	EnzymesIBA 02/2017 - 03/2013
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2016 - 05/2002
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2013 - 10/2009
3	Antiviral Agents (Antivirals)IBA 01/2013 - 07/2011
3	Fas Ligand Protein (Fas Ligand)IBA 06/2011 - 03/2004
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2008 - 05/2002
3	Caspase 3 (Caspase-3)IBA 09/2005 - 07/2003
3	plerixafor FDA Link 04/2005 - 10/2003
2	mirdametinibIBA 01/2024 - 01/2023
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2023 - 12/2018
2	C-Reactive ProteinIBA 01/2023 - 11/2021
2	AntibodiesIBA 09/2022 - 12/2020
2	Triggering Receptor Expressed on Myeloid Cells-1IBA 01/2022 - 09/2016
2	EndotoxinsIBA 01/2022 - 11/2012
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 11/2021 - 01/2021
2	P-SelectinIBA 11/2021 - 08/2013
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 11/2021 - 01/2019
2	LeptinIBA 10/2021 - 01/2011
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 01/2019
2	ivacaftorIBA 04/2020 - 01/2020
2	AntigensIBA 01/2019 - 02/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 08/2013
2	HMGB1 Protein (HMG1)IBA 01/2019 - 03/2013
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 02/2017
2	Interleukin-10 (Interleukin 10)IBA 01/2019 - 06/2011
2	Interleukin-8 (Interleukin 8)IBA 12/2018 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 12/2018 - 07/2005
2	Transcription Factors (Transcription Factor)IBA 02/2017 - 03/2006
2	ImmunosorbentsIBA 01/2017 - 03/2013
2	Oxidants (Oxidizing Agents)IBA 11/2016 - 01/2003
2	Endothelial Growth FactorsIBA 01/2016 - 05/2011

Therapy/Procedure

40	Therapeutics 01/2024 - 11/2002
7	Artificial Respiration (Mechanical Ventilation) 01/2021 - 09/2005
6	Ligation 01/2021 - 06/2003
5	Punctures 01/2021 - 10/2010
3	Drug Therapy (Chemotherapy) 12/2017 - 12/2011
2	Precision Medicine 07/2023 - 01/2023
2	Critical Care (Surgical Intensive Care) 01/2022 - 09/2009
2	Transplantation 01/2021 - 11/2002